Foliglurax
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Foliglurax, covering 2018-03-22 to 2018-03-22. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED) [Phase 2]